Vismodegib: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Vismodegib. Educational only — not medical advice.
Labeled uses
ERIVEDGE is indicated for the treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery and who are not candidates for radiation.
Source: FDA labeling via NIH DailyMed (set eb368bb6…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.